Evaluating Sacubitril/Valsartan Dose Dependence on Clinical Outcomes in Patients With Heart Failure With Reduced Ejection Fraction

BackgroundLimited evidence is available regarding low (24/26 mg) and middle (49/51 mg) doses of sacubitril/valsartan.ObjectivesThe purpose of this study was to investigate the effect of sacubitril/...